Form 4: Stryker Corp Executive Exercises Stock Options and Sells Shares

A Stryker Corp executive, Spencer S. Stiles, exercised stock options and sold shares on January 29, 2025, resulting in a change in his beneficial ownership.

Summary

• Spencer S. Stiles, a Group President at Stryker Corp, exercised 10,210 stock options at a price of $93.06 per share on January 29, 2025.
• Following the exercise of options, Mr. Stiles sold 5,448 shares at a price of $395.15 per share on the same day.
• After these transactions, Mr. Stiles directly owns 55,373 shares of Stryker common stock.
• He also indirectly owns 1,637 shares through a 401K.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself.

Industry Context

This is a routine filing related to executive stock option exercises and sales, which is common in publicly traded companies. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice in publicly traded companies, particularly in the healthcare and medical device industry where Stryker operates.
• The timing and pricing of these transactions are often governed by pre-arranged plans to avoid any appearance of insider trading.
• Similar filings are regularly made by executives at comparable companies such as Medtronic, Johnson & Johnson, and Boston Scientific.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the sale of shares by an executive, but this is generally expected and factored into market valuations.

Key Dates

Keywords

Stryker Corp, stock options, insider trading, executive compensation, share sale, beneficial ownership, SEC Form 4